Bionexus Gene LabBGLC
13F holders, Q2 2025 (June 30)1holders
$3.07avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Bionexus Gene Lab Corp. (BGLC) in their 13F filings. The largest holder was UBS Group AG ($29K).
- Company
- Bionexus Gene Lab Corp.
- CUSIP
- 090628306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 0 | $0 |
Ownership 1 holders
| UBS Group AG | 0.00% | New | 9,562 | $29K |
"% of holder's portfolio" is BGLC's weight in each manager's 13F, not the share of Bionexus Gene Lab Corp. the manager owns.